Joseph M. Galvin Iii

Array ( [id] => 7404335 [patent_doc_number] => 20040023976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Treatment of gastrointestinal stromal tumors' [patent_app_type] => new [patent_app_number] => 10/415015 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3112 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023976.pdf [firstpage_image] =>[orig_patent_app_number] => 10415015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814165 [patent_doc_number] => 20030073715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Apomorphine-containing dosage form for ameliorating male erectile dysfunction' [patent_app_type] => new [patent_app_number] => 10/044588 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16941 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073715.pdf [firstpage_image] =>[orig_patent_app_number] => 10044588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381819 [patent_doc_number] => 20020119993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Potentiator for neurotrophin effect' [patent_app_type] => new [patent_app_number] => 09/981367 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7690 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119993.pdf [firstpage_image] =>[orig_patent_app_number] => 09981367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6553997 [patent_doc_number] => 20020111384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Method of treating alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/977533 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4808 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111384.pdf [firstpage_image] =>[orig_patent_app_number] => 09977533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475588 [patent_doc_number] => 06388053 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods' [patent_app_type] => B1 [patent_app_number] => 09/975905 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6685 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388053.pdf [firstpage_image] =>[orig_patent_app_number] => 09975905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765290 [patent_doc_number] => 20030099688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Animal feeds including heartworm-prevention drugs' [patent_app_type] => new [patent_app_number] => 09/971520 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4469 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099688.pdf [firstpage_image] =>[orig_patent_app_number] => 09971520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131341 [patent_doc_number] => 20020077301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors ' [patent_app_type] => new [patent_app_number] => 09/971365 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5277 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077301.pdf [firstpage_image] =>[orig_patent_app_number] => 09971365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754683 [patent_doc_number] => 07019016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'NMDA NR2B antagonists for treatment' [patent_app_type] => utility [patent_app_number] => 09/969317 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10118 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019016.pdf [firstpage_image] =>[orig_patent_app_number] => 09969317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697328 [patent_doc_number] => 20030109522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Ophthalmologic treatment methods using selective iNOS inhibitors' [patent_app_type] => new [patent_app_number] => 09/961816 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51087 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109522.pdf [firstpage_image] =>[orig_patent_app_number] => 09961816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441737 [patent_doc_number] => 20020128434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors' [patent_app_type] => new [patent_app_number] => 09/953590 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15664 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128434.pdf [firstpage_image] =>[orig_patent_app_number] => 09953590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082569 [patent_doc_number] => 20020082264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Medicaments for viral diseases' [patent_app_type] => new [patent_app_number] => 09/943046 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23257 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082264.pdf [firstpage_image] =>[orig_patent_app_number] => 09943046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1421065 [patent_doc_number] => 06506790 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Compounds and methods' [patent_app_type] => B1 [patent_app_number] => 09/914502 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9119 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506790.pdf [firstpage_image] =>[orig_patent_app_number] => 09914502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313458 [patent_doc_number] => 06610720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Method for treating or preventing emesis' [patent_app_type] => B2 [patent_app_number] => 09/939175 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610720.pdf [firstpage_image] =>[orig_patent_app_number] => 09939175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829202 [patent_doc_number] => 20020068720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading' [patent_app_type] => new [patent_app_number] => 09/933366 [patent_app_country] => US [patent_app_date] => 2001-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5113 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068720.pdf [firstpage_image] =>[orig_patent_app_number] => 09933366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064116 [patent_doc_number] => 20020032156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders' [patent_app_type] => new [patent_app_number] => 09/925419 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2550 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032156.pdf [firstpage_image] =>[orig_patent_app_number] => 09925419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815266 [patent_doc_number] => 20020040052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Method for neurite outgrowth' [patent_app_type] => new [patent_app_number] => 09/927038 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5828 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040052.pdf [firstpage_image] =>[orig_patent_app_number] => 09927038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420523 [patent_doc_number] => 06514999 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Use of an agent for treating the symptoms of Parkinson\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/857313 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1323 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514999.pdf [firstpage_image] =>[orig_patent_app_number] => 09857313 [rel_patent_id] =>[rel_patent_doc_number] =>)